Search
The long and winding road for the drug Embeda® (morphine sulfate and naltrexone hydrochloride) appears to be nearing its end. The manufacturer, Pfizer, has not yet released any public information, but the Food and Drug Administration (FDA) has posted on its website the date of November 15, 2019,...
Recently, myMatrixx Chief Clinical Officer, Phil Walls, sat down with Risk & Insurance Magazine for an interview where he discusses a range of topics surrounding the high cost of drugs in the current marketplace. The conversation takes place ahead of his presentation at the 2019 National Workers’...
In the second part of a two-part feature in Risk & Insurance Magazine on myMatrixx’s clinical and data analytics suite, myRXAdvocate SM , Chief Clinical Officer, Phil Walls and Vice President of Business Intelligence, Cliff Belliveau continue to share their insights. This article primarily focuses...
A recent article in Risk & Insurance Magazine, the first of two, quotes Phil Walls, myMatrixx Chief Clinical Officer, and Cliff Belliveau, Vice President of Business Intelligence, as they discuss our exciting new myRXAdvocateSM Program. The piece focuses on the traditionally reactive nature of...
The myMatrixx team is excited to be attending and exhibiting at this year’s National Workers’ Compensation and Disability Conference , which will be held November 6-8 in Las Vegas, Nevada. A key part of our presence at the event will be speaking engagements from Chief Clinical Officer, Phil...
myMatrixx has added Sarah Wasselle to their Business Intelligence team, joining as a Senior Business Systems Analyst and Developer. Sarah graduated from the University of Florida with a degree in Industrial Engineering and is currently pursuing a master's from the University of South Florida in...
myMatrixx has added a new Clinical Account Executive to their team, Shanea McKinney, PharmD . Prior to joining myMatrixx, Shanea served as Director Client Services, Managed Care for Sedgwick . In her role, Shanea worked with Sedgwick Program Managers and key clients to provide analytical support...
The Centers for Disease Control and Prevention (CDC) was the first to sound the alarm on the U.S. opioid epidemic. For years, the CDC tracked the epidemic and shared the alarming statistics with the medical community in hopes that it would make an impact, yet opioid overdose deaths continued to rise....
myMatrixx Chief Clinical Officer, Phil Walls, has been named a panelist in one of the 2019 National Workers’ Compensation and Disability Conference® & Expo's most anticipated conference sessions: '60 Tips in 60 Minutes – Avoiding Medical Mismanagement’s Claims Fallout.' Risk & Insurance...